Shin S, Branning R, McGinnis M, Shin A, Ho M, Karpyak V
Clin Transl Sci. 2025; 18(3):e70180.
PMID: 40065582
PMC: 11893730.
DOI: 10.1111/cts.70180.
Scholand K, Schaefer L, Govindarajan G, Yu Z, Galletti J, de Paiva C
Geroscience. 2025; .
PMID: 40053297
DOI: 10.1007/s11357-025-01576-y.
Lee K, Mei Y, Liu H, Schwarz H
Mol Ther. 2024; 33(1):51-70.
PMID: 39668561
PMC: 11764688.
DOI: 10.1016/j.ymthe.2024.12.010.
Truffin D, Marchand F, Chatelais M, Chene G, Saias L, Herbst F
Int J Mol Sci. 2024; 25(17).
PMID: 39273695
PMC: 11396153.
DOI: 10.3390/ijms25179748.
Chen D, Zhou Z, Kong N, Xu T, Liang J, Xu P
Sci Adv. 2024; 10(37):eado1749.
PMID: 39270015
PMC: 11397428.
DOI: 10.1126/sciadv.ado1749.
Non-invasive detection of regulatory T cells with Raman spectroscopy.
Pavillon N, Lim E, Tanaka A, Hori S, Sakaguchi S, Smith N
Sci Rep. 2024; 14(1):14025.
PMID: 38890425
PMC: 11189440.
DOI: 10.1038/s41598-024-64536-0.
A comprehensive analysis of the immune system in healthy Vietnamese people.
Huynh D, Nguyen M, Ngo D, Nguyen X, Nguyen D, Mai T
Heliyon. 2024; 10(9):e30647.
PMID: 38765090
PMC: 11101793.
DOI: 10.1016/j.heliyon.2024.e30647.
GITR exacerbates lysophosphatidylcholine-induced macrophage pyroptosis in sepsis via posttranslational regulation of NLRP3.
Liang S, Zhou J, Cao C, Liu Y, Ming S, Liu X
Cell Mol Immunol. 2024; 21(7):674-688.
PMID: 38740925
PMC: 11214634.
DOI: 10.1038/s41423-024-01170-w.
The Potential of FOXP3 in Predicting Survival and Treatment Response in Breast Cancer.
Liu L, Xiao W, Zhang C, Fan P, Zeng J, Yi J
Int J Gen Med. 2024; 17:1233-1251.
PMID: 38562210
PMC: 10984197.
DOI: 10.2147/IJGM.S454421.
Engaging stimulatory immune checkpoint interactions in the tumour immune microenvironment of primary liver cancers - how to push the gas after having released the brake.
Rakke Y, Buschow S, IJzermans J, Sprengers D
Front Immunol. 2024; 15:1357333.
PMID: 38440738
PMC: 10910082.
DOI: 10.3389/fimmu.2024.1357333.
Beyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity.
Santosh Nirmala S, Kayani K, Gliwinski M, Hu Y, Iwaszkiewicz-Grzes D, Piotrowska-Mieczkowska M
Front Immunol. 2024; 14:1321228.
PMID: 38283365
PMC: 10811018.
DOI: 10.3389/fimmu.2023.1321228.
Fcγ receptors and immunomodulatory antibodies in cancer.
Galvez-Cancino F, Simpson A, Costoya C, Matos I, Qian D, Peggs K
Nat Rev Cancer. 2023; 24(1):51-71.
PMID: 38062252
DOI: 10.1038/s41568-023-00637-8.
Host Genetic Variation Has a Profound Impact on Immune Responses Mediating Control of Viral Load in Chronic Gammaherpesvirus Infection.
Holt E, Waytashek C, Sessions K, Asarian L, Lahue K, Usherwood E
J Immunol. 2023; 211(10):1526-1539.
PMID: 37819784
PMC: 10841120.
DOI: 10.4049/jimmunol.2300294.
"IL-2 immunotherapy for targeting regulatory T cells in autoimmunity".
Lykhopiy V, Malviya V, Humblet-Baron S, Schlenner S
Genes Immun. 2023; 24(5):248-262.
PMID: 37741949
PMC: 10575774.
DOI: 10.1038/s41435-023-00221-y.
Lrig1-expression confers suppressive function to CD4 cells and is essential for averting autoimmunity via the Smad2/3/Foxp3 axis.
Moon J, Ho C, Park J, Park K, Shin B, Lee S
Nat Commun. 2023; 14(1):5382.
PMID: 37666819
PMC: 10477202.
DOI: 10.1038/s41467-023-40986-4.
CD4 Phenotypes Are Associated with Reduced Expansion of Tumor-Infiltrating Lymphocytes in Melanoma Patients Treated with Adoptive Cell Therapy.
Thompson B, Strange A, Amato C, Hester-McCullough J, Sarnaik A, Weber J
J Immunol. 2023; 211(5):735-742.
PMID: 37466381
PMC: 10528290.
DOI: 10.4049/jimmunol.2300250.
TNF superfamily control of tissue remodeling and fibrosis.
Steele H, Cheng J, Willicut A, Dell G, Breckenridge J, Culberson E
Front Immunol. 2023; 14:1219907.
PMID: 37465675
PMC: 10351606.
DOI: 10.3389/fimmu.2023.1219907.
Treg-based immunotherapy for antigen-specific immune suppression and stable tolerance induction: a perspective.
Sakaguchi S, Kawakami R, Mikami N
Immunother Adv. 2023; 3(1):ltad007.
PMID: 37397971
PMC: 10309084.
DOI: 10.1093/immadv/ltad007.
Targeting GITR in cancer immunotherapy - there is no perfect knowledge.
Davar D, Zappasodi R
Oncotarget. 2023; 14:614-621.
PMID: 37335294
PMC: 10278658.
DOI: 10.18632/oncotarget.28461.
The role of regulatory T cells and follicular T helper cells in HBV infection.
Lin N, Yin W, Miller H, Byazrova M, Herrada A, Benlagha K
Front Immunol. 2023; 14:1169601.
PMID: 37275865
PMC: 10235474.
DOI: 10.3389/fimmu.2023.1169601.